Abstract
Streptomyces, a prominent genus within the Actinomycetota phylum, is responsible for over 60% of clinically relevant antibiotics. Streptomyces strains inhabiting plant roots possess the potential to synthesize bioactive natural products, conferring defense and resilience to plants against pathogenic microorganisms. However, this potential remains largely unexplored. This study aims to screen for bioactive metabolites produced by Streptomyces strains in the plant rhizosphere.
Six Streptomyces isolates were cultivated using three modified media to induce the production of diverse metabolites, employing the One Strain Many Compounds (OSMAC) approach. The metabolites present in extracts from fermentation broths were examined through a non-targeted Liquid Chromatography-Tandem Mass Spectrometry (LC–MS/MS) approach coupled with Global Natural Products Social Molecular Networking (GNPS MN). The antimicrobial activity of the extracts was assessed using the disc diffusion method.
The strains demonstrated a wide-ranging antimicrobial efficacy against all examined organisms. The GNPS molecular network analyses reveal that metabolite profiles in extracts can exhibit variations based on the medium and solvent system employed. Notably, the ethyl acetate and dichloromethane extracts from Streptomyces sp. CAH29, cultivated in Glucose-Yeast Extract Medium (GYM), exhibited inhibition diameters of up to 30 mm against both Staphylococcus aureus and Candida albicans. Within the metabolomes of these strains, the antibiotics spiramycin and actinomycin were detected. Additionally, lyngbatoxin, a tumor promoter, and potential new analogs were identified. Significantly, a considerable portion of the produced metabolites did not align with any known compounds, indicating the existence of unidentified metabolites generated by these strains. This suggests the possibility of introducing novel chemical entities.
Our study illustrated that Streptomyces strains associated with plant roots could be considered a valuable source of bioactive secondary metabolites. Furthermore, the metabolomics approach utilized in this study serves as a rapid and valuable tool for the screening of microorganisms capable of producing bioactive metabolites.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are openly available in the GNPS database at https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=b4d62c82bdc446ddb073b0aab6194587.
References
Amann, S., Neef, K., & Kohl, S. (2019). Antimicrobial resistance (AMR). European Journal of Hospital Pharmacy, 26(3), 175–177.
Newman, D. J., & Cragg, G. M. (2016). Natural Products as Sources of New Drugs from 1981 to 2014. Journal of Natural Products, 79(3), 629–661.
Newman, D. J., & Cragg, G. M. (2020). Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. Journal of Natural Products, 83(3), 770–803.
Alam, K., Mazumder, A., Sikdar, S., Zhao, Y. M., Hao, J., Song, C., Wang, Y., Sarkar, R., Islam, S., Zhang, Y., & Li, A. (2022). Streptomyces: The biofactory of secondary metabolites. Frontiers in Microbiology, 13, 968053.
Procópio, R. E., Silva, I. R., Martins, M. K., Azevedo, J. L., & Araújo, J. M. (2012). Antibiotics produced by Streptomyces. Brazilian Journal Infectious Diseases, 16(5), 466–471.
Waters, M., & Tadi, P. (2023). Streptomycin. StatPearls Publishing.
Lee, J. H., Anderson, A. J., & Kim, Y. C. (2022). Root-Associated Bacteria Are Biocontrol Agents for Multiple Plant Pests. Microorganisms, 10(5), 1–25.
Kaur, T., Jasrotia, S., Ohri, P., & Manhas, R. K. (2016). Evaluation of in vitro and in vivo nematicidal potential of a multifunctional streptomycete, Streptomyces hydrogenans strain DH16 against Meloidogyne incognita. Microbiological Research, 192, 247–252.
Yilmaz, E. I., Yavuz, M., & Kızıl, M. (2008). Molecular characterization of rhizospheric soil Streptomycetes isolated from indigenous Turkish Plants and their antimicrobial activity. World Journal of Microbiology and Biotechnology, 24(8), 1461–1470.
Sivalingam, P., Hong, K., Pote, J., & Prabakar, K. (2019). Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? International Journal of Microbiology eCollection, 2019, 1–20.
Aryal, S., Neupane, L., Adhikari, R., Regmi, B., Koirala, N., et al. (2021). Novel Streptomyces sp. reported in 2018: A Meta-Analysis. Anti-infective Agents, 19(5), 1–11.
Wang, M., Carver, J. J., Phelan, V. V., Sanchez, L. M., Garg, N., et al. (2016). Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nature Biotechnology, 34(8), 828–837.
Bode, H. B., Bethe, B., Höfs, R., & Zeeck, A. (2002). Big effects from small changes: Possible ways to explore nature’s chemical diversity. ChemBioChem, 3(7), 619–627.
Romano, S., Jackson, S. A., Patry, S., & Dobson, A. D. W. (2018). Extending the “one strain many compounds” (OSMAC) principle to marine microorganisms. Marine Drugs, 16(7), 1–29.
Kum, E., & İnce, E. (2021). Genome-guided investigation of secondary metabolites produced by a potential new strain Streptomyces BA2 isolated from an endemic plant rhizosphere in Turkey. Archives of Microbiology, 203(5), 2431–2438.
Clark, C. L., Jacobs, M. R., & Appelbaum, P. C. (1998). Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies. Journal of Clinical Microbiology, 36(12), 3579–3584.
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., et al. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504.
Sanchez, S., Chavez, A., Forero, A., Garcia-Huante, Y., Romero, A., et al. (2010). Carbon source regulation of antibiotic production. The Journal of Antibiotics, 63(8), 442–459.
Martin, J. F., Sola-Landa, A., Santos-Beneit, F., Fernandez-Martinez, L. T., Prieto, C., et al. (2011). Cross-talk of global nutritional regulators in the control of primary and secondary metabolism in Streptomyces. Microbial Biotechnology, 4, 165–174.
Machushynets, N. V., Wu, C., Elsayed, S. S., Hankemeier, T., & van Wezel, G. P. (2019). Discovery of novel glycerolated quinazolinones from Streptomyces sp. MBT27. J Industrial Microbiology and Biotechnology, 46, 483–492.
Schwarz, J., Hubmann, G., Rosenthal, K., & Lütz, S. (2021). Triaging of culture conditions for enhanced secondary metabolite diversity from different bacteria. Biomolecules, 11(2), 193. 1-23.
Pinnert-Sindico, S. (1954). Une nouvelle espece de Streptomyces productrice d’antibiotiques: Streptomyces ambofaciens n. sp. caractères culturaux. Annales de l’Institut Pasteur, 87, 702–707.
Cardellina, J. H., Marner, F. J., & Moore, R. E. (1979). Seaweed dermatitis: structure of lyngbyatoxin A. Science, 204, 193–195.
Takashima, M., & Sakai, H. (1960). A new toxic substance, teleocidin, produced by Streptomyces. Part I. Production, isolation, and chemical studies. Bulletin of the Agricultural Chemical Society of Japan., 24, 647–651.
Nakayasu, M., Fujiki, H., Mori, M., Sugimura, T., & Moore, R. E. (1981). Teleocidin, lyngbyatoxin A, and their hydrogenated derivatives, possible tumor promoters, induce terminal differentiation in HL-60 cells. Cancer Letters, 12, 271–277.
Funding
This study was supported by the Dicle University Scientific Research Projects Committee [Grant number: FEN.17.016].
Author information
Authors and Affiliations
Contributions
This research was conducted by the authors identified in this article and said authors assume full responsibility for any claims pertaining to this article and its contents.
Corresponding author
Ethics declarations
Ethics Approval
Not applicable.
Consent to Participate
Informed consent was obtained from two participants included in the study.
Consent for Publication
The authors give the consent for publication.
Conflict of Interest
No conflict of interest was declared.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kum, E., İnce, E. Metabolomics Approach to Explore Bioactive Natural Products Derived From Plant-Root-Associated Streptomyces. Appl Biochem Biotechnol (2024). https://doi.org/10.1007/s12010-024-04905-7
Accepted:
Published:
DOI: https://doi.org/10.1007/s12010-024-04905-7